Italian Medicines Agency Aifa toggle bar Search Search keywords The Agency The Agency Mission and values Organisation Scientific and Economic Committee for Medicines Support and Coordination Secretariats and Advisory Committees International Collaborations EU Projects Legislation Forms Competition notices Resolutions Tenders and contracts Quality assurance Guarantee Committee Atti di notifica Associazioni dei pazienti AIFA Incontra Contacts Certified email COVID-19 COVID-19 Communications about COVID-19 COVID-19 Vaccines Medicines usable for treatment of COVID-19 disease Use of monoclonal antibodies for COVID-19 Use of antivirals for COVID-19 Monitoring of medicinal products used during the COVID-19 epidemic Clinical Trials - COVID-19 Compassionate Use Programs - COVID-19 Access to medicinal products Access to medicinal products Early access and off-label use Authorisation of medicinal products Medicine shortages Antibiotic medicinal products Biological medicinal products Vaccines Blood derivatives Generic medicinal products Biosimilar medicinal products Orphan medicinal products Advanced therapies Homeopathic medicinal products Allergens Medicinali di origine vegetale Ancillary medicinal substances incorporated in medical devices Safety of medicinal products Safety of medicinal products Pharmacovigilance National Pharmacovigilance Network Adverse Reactions to medicinal products Persons in charge of Pharmacovigilance European Eudravigilance System Accesso alle segnalazioni - ADRreports Regional pharmacovigilance funds Segnali di sicurezza Risk management measures Medicinal products subject to additional monitoring Quality and Inspections Quality and Inspections Quality defects Inspections and authorisations Qualified person Fight of pharmaceutical crime Research and Clinical trials Research and Clinical trials Clinical trials concerning medicinal products EU Regulation on Clinical trials National Observatory on Clinical Trials Registro Studi Osservazionali Comitati Etici Nazionali (CEN) Ethics Committees Coordination Centre Independent clinical research Mappa dei centri di Sperimentazione Clinica Pricing and reimbursement Pricing and reimbursement Negotiation and reimbursement Economic evaluations Monitoring Registers AIFA Notes Lists of Class A and Class H medicinal products Innovative medicinal products Transparency Lists Consumption and pharmaceutical expenditure Consumption and pharmaceutical expenditure The Medicines Utilization Monitoring Centre (OsMed) Governance of pharmaceutical expenditure Monitoring pharmaceutical expenditure Innovation and planning Innovation and planning Innovation and scientific advice Horizon scanning Information and communication Information and communication FarmaciLine Medical and scientific information FAQ Publications Communication campaigns Eventi AIFA Scientific Seminars Press releases Dossier AIFA Mobile APP AIFA APP Firstline AIFA - Antibiotici ABC della Ricerca Clinica Presentations and speeches Public consultations and documents Documents shared with scientific communities Calendario eventi Archivio AIFA data AIFA data OsMed Data Open Data Companies Section Companies Section Requests for authorisation of conferences and meetings Payment of fees and annual duties MA Electronic invoicing Application for reimbursement and pricing Access information Notifica concessionari di vendita Comunicazione prima commercializzazione Open governance Open governance Disposizioni Generali Organizzazione Consulenti e collaboratori Personale Bandi di Concorso Performance Enti controllati Attività e procedimenti Provvedimenti Bandi di gara e contratti Sovvenzioni, contributi, sussidi, vantaggi economici Bilanci Beni immobili e gestione patrimonio Controlli e rilievi sull'Amministrazione Servizi Erogati Pagamenti dell'Amministrazione Opere pubbliche Pianificazione e governo del territorio Informazioni ambientali Interventi straordinari di emergenza Altri Contenuti Asset Publisher Highlights 21 Apr 2026 The Medicines Utilization Monitoring Centre (OsMed) Medicine Use: 2024 Regional Reports Now Available Online AIFA has published the Regional Reports on Medicine Consumption, which provide an analytical and detailed overview of medicine use within each Region during 2024. 17 Apr 2026 Press releases From one-size-fits-all treatments to personalised care: the revolution in precision medicine The new AIFA report examines the clinical and economic impact of targeted therapies and prescriptomics 08 Apr 2026 Press releases Regulations for AIFA Incontra and AIFA Ascolta Approved The Agency strengthens dialogue with stakeholders and promotes listening and transparency. 26 Mar 2026 Information and communication How to protect yourself from fake ‘miracle cures’: AIFA recommendations To avoid the risk of fraud and protect yourselves from so-called ‘miracle cures’ based on stem cells, AIFA urges patients and their families to follow a few simple recommendations. Asset Publisher News 15 Apr 2026 Transparency Lists AIFA updates the Transparency Lists 10 Apr 2026 Safety of medicinal products Meeting highlights from PRAC ( 7- 10 April 2026) 02 Apr 2026 Press releases AIFA executives on institutional mission to Japan for the first time 27 Mar 2026 Safety of medicinal products Levamisole: the PRAC recommendation for withdrawal from the EU market has been confirmed 26 Mar 2026 Press releases The Board of Directors has given the go-ahead for reimbursing a new medicine, seven extensions of therapeutic indications and three generic equivalents 24 Mar 2026 Press releases Drug negotiations: new ‘simplified’ and ‘fast-track’ procedures launched All news Banca dati dei farmaci 2024 Find your medicine Safety of medicinal products Report an adverse reaction Medicine shortages FarmaciLine Questions regarding drug efficacy, safety and availability TOLL-FREE NUMBER 800.571.661 REXPONDO SYSTEM Services Services A chi rivolgersi Scarica l'App Medicinali AIFA Provvedimenti AIFA in Gazzetta Ufficiale Hero AIFA con links homepage Interactive OsMed - The use of medicines in Italy An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology AIFA Data OsMed Data Open data Asset Publisher Agenda 18 - 22 MAY Roma Da definire CSE Riunione della Commissione Scientifica e Economica del Farmaco (CSE) 27 MAY Roma 10:30 CDA Riunione CDA 10 JUN Roma 10:30 CDA Riunione CDA ALL EVENTS Asset Publisher Press releases From one-size-fits-all treatments to personalised care: the revolution in precision medicine All press releases Media Media Asset Publisher Multimedia Go to YouTube channel VAI AL PROFILO INSTAGRAM Asset Publisher Companies Section Online services Cookie Bar Footer The agency Home Page FarmaciLine User participation and satisfaction Citizens' access Modulistica Open governance Acts of notification Legal notification TrovaNormeFarmaco Competition notices Tenders and contracts Contacts Via del Tritone, 181 00187 Roma Contacts Certified e-mail (PEC) contacts VAT number: 08703841000 Tax code: 97345810580 IPA AIFA code: aifa_rm IPA UCB code: UFE1TR FOLLOW US ON label.button.spotify Bluesky FEED RSS Feed Rss Cookie management Sezione Link Utili Legal notice Social Media Policy Dichiarazione di accessibilità Web accessibility Website statistics Online services go to beginning of content